2936 Results Page 282 of 294

A PHASE IIB, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CK-2017357 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Jackson,Carlayne E

Funded by

CYTOKINETICS

Inactive Project

Neuroscience

Clinical Care

Drug Discovery

GENERATION OF HUMAN-DERIVED NEURONS FOR THE STUDY OF PSYCHIATRIC DISORDERS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Lechleiter,James D

Funded by

UT HLTH SCI CENTER AT HOUSTON

Inactive Project

Neuroscience

Basic Research

Georgia Bioscience Fellowship Program, Ana Kapanadze

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Eppinger, Mark

Funded by

CRDF Global

Scholarship & Fellowship

Collaborative Project

Inactive Project

Infectious Disease

Basic Research

PREVENTION OF BRCA1-ASSOCIATED BREAST CANCER BY ELIMINATING THE CELL OF ORIGIN

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Li,Rong

Funded by

AVON FOUNDATION

Inactive Project

Cancer

Basic Research

STEM CELLS AS A NOVEL THERAPEUTIC APPROACH FOR BIPOLAR DISORDER AND AUTISM

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Lodge,Daniel J

Funded by

WILLIAM & ELLA OWENS MED RSCH FOUNDATION

Inactive Project

Neuroscience

Basic Research

TESTING NOVEL DRUGS TARGETING THE BETA-III-TUBULIN ISOTYPE IN BREAST CANCER

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Luduena,Richard F

Funded by

ARMY MED RESEARCH ACQUISITION ACTIVITY

Inactive Project

Cancer

Basic Research

MECHANISM OF MICROBIOME-INDUCED INSULIN RESISTANCE IN HUMANS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Musi,Nicolas

Funded by

AMERICAN DIABETES ASSOCIATION

Inactive Project

Diabetes and Obesity

Basic Research

TARGETING CANCER CELLS FOR DEATH WITH THE VIRAL ANTI-CANCER AGENT REOLYSIN

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Nawrocki,Steffan T

Funded by

WILLIAM & ELLA OWENS MED RSCH FOUNDATION

Inactive Project

Cancer

Clinical Care

TARGETING ACTIVATED RAS IN PANCREATIC CANCER WITH REOVIRUS THERAPY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Nawrocki,Steffan T

Funded by

VOELCKER FUND

Inactive Project

Cancer

Clinical Care

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF A HUMAN MONOCLONAL ANTIBODY, REGN2222, FOR THE PREVENTION OF MEDICALLY ATTENDED RSV INFECTION IN PRETERM INFANTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Odom,Michael W

Funded by

REGENERON PHARMACEUTICALS

Inactive Project

Infectious Disease

Clinical Care

Drug Discovery

Bioscience Research Panel